SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-13-001784
Filing Date
2013-05-14
Accepted
2013-05-14 16:02:13
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_033113.htm 10-Q 888859
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 18198
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 19027
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 8676
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 8365
  Complete submission text file 0001387131-13-001784.txt   4024212

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20130331.xml EX-101.INS 521422
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20130331.xsd EX-101.SCH 29535
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20130331_cal.xml EX-101.CAL 42117
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20130331_def.xml EX-101.DEF 96750
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20130331_lab.xml EX-101.LAB 207818
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20130331_pre.xml EX-101.PRE 169369
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-88480 | Film No.: 13841519
SIC: 2834 Pharmaceutical Preparations